Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

At the end of the treatment phase, researchers measured changes in knee pain ... the semaglutide group lost at least 10% of ...

Yuhan Corp. posted record-breaking third-quarter results, with revenue reaching 598.8 billion won and operating profit ...

The prevalence of osteoarthritis (OA) is rising in Canada, largely due to an ageing population and higher obesity rates.

Enlivex Therapeutics (ENLV) announced the enrollment and dosing of the first 10 patients in the randomized Phase II stage of the ...

As the number of people with osteoarthritis, sports-related knee injuries ... especially in developing countries, is ...

But the good news is, getting tested is usually quick, easy, and painless. And STDs can be cured or treated. Planned Parenthood health centers offer STD testing and treatment, and our caring and ...

The demand for ACL replacement procedures is driven by the need for effective treatment options that restore knee ... The dominance is attributed to the high incidence of knee injuries, particularly ...